Alongside these morphological shifts, CMs from glioma cells also enhanced the expression of surface marker CD206 (Fig. 2D), instead of CD86 (Fig. S2D), indicating a shift towards M2-like polarization, evidenced by immunofluorescent staining. Here, MRC1 is linked to central nervous system cancer.